close 74% dei conti retail perde denaro a causa delle negoziazioni in CFD con questo fornitore. Gli investimenti comportano rischi e non sono adatti a tutti gli investitori. I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva finanziaria. 74% dei conti degli investitori al dettaglio perde denaro quando fa trading di CFD con questo fornitore. Dovresti prendere in considerazione se comprendi come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.
Change languageItaliano
Dashboard

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Home・Elenco Azioni・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Chiusa

SettoreSettore sanitario

2.33 3.56

Fortemente da comprare

Aggiornamento del prezzo 24 ott 2025, 19:50 UTC

AcquistaVendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.29

Massimo

2.33

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+209.33% upside

Dividendi

By Dow Jones

Utili prossimi

13 nov 2025

Notizie sul Sentiment di mercato

By Acuity

50%

50%

145 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

1.76 / 1.94 Supporto e resistenza

Inovio Pharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 ott 2025, 18:41 UTC

Utili

Procter & Gamble to Focus on Innovation, Not Discounts, to Attract Wary Shoppers - 2nd Update

DJ

LeggI

24 ott 2025, 18:31 UTC

Utili

Correction to Procter & Gamble to Focus on Innovation

DJ

LeggI

24 ott 2025, 16:25 UTC

I principali Market Mover

Obook Shares Rise, Company Secures New Money Transmitter Licenses

DJ

LeggI

24 ott 2025, 21:24 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

DJ

LeggI

24 ott 2025, 21:24 UTC

Discorsi di Mercato

Moody's Sees France With Increased Risk of Political Dysfunction -- Market Talk

DJ

LeggI

24 ott 2025, 21:07 UTC

Utili

The Score: Netflix, Amazon.com, Six Flags and More Stocks That Defined the Week -- WSJ

DJ

LeggI

24 ott 2025, 20:58 UTC

Utili

S&P 500 Climbs to New Record on Strong Earnings -- WSJ

DJ

LeggI

24 ott 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

DJ

LeggI

24 ott 2025, 20:40 UTC

Utili

Intel Expects Chip Shortages on Better PC Demand. Here's Why AMD Is Winning Too. -- Barrons.com

DJ

LeggI

24 ott 2025, 20:24 UTC

Utili

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

DJ

LeggI

24 ott 2025, 20:23 UTC

Utili

General Dyamics Stock Rises on Earnings. Aerospace Was a Standout. -- Barrons.com

DJ

LeggI

24 ott 2025, 20:13 UTC

Utili

These Stocks Moved the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

DJ

LeggI

24 ott 2025, 20:07 UTC

Discorsi di Mercato

Different-Cell Imputation Rose Proportionally in September CPI -- Market Talk

DJ

LeggI

24 ott 2025, 19:40 UTC

Discorsi di Mercato

Treasury Yields Mixed, Dollar Stronger Ahead of Fed Week -- Market Talk

DJ

LeggI

24 ott 2025, 19:35 UTC

Discorsi di Mercato

Oil Rally on U.S. Russia Sanctions Loses Steam -- Market Talk

DJ

LeggI

24 ott 2025, 19:33 UTC

Utili

IBM and Google Are Also Making Moves in Quantum. Don't Count Out the Bigger Players. -- Barrons.com

DJ

LeggI

24 ott 2025, 19:29 UTC

Discorsi di Mercato

U.S. Natural Gas Ends Week Higher on Weather Outlook -- Market Talk

DJ

LeggI

24 ott 2025, 18:52 UTC

Utili

Correction to GM Stock Soars to Record High. Earnings Were So Good, They Helped Ford. -- Barrons.com

DJ

LeggI

24 ott 2025, 18:41 UTC

Utili

GM Stock Soars to Record High. Earnings Were So Good, They Helped Ford. -- Barrons.com

DJ

LeggI

24 ott 2025, 18:03 UTC

Utili

Beyond Meat Stock Is on a Wild Ride. Why a Meme Rally Looks Undercooked. -- Barrons.com

DJ

LeggI

24 ott 2025, 18:02 UTC

Utili

Progressive Stock Got Hit After Earnings. It's Time to Buy One of America's Great Companies. -- Barrons.com

DJ

LeggI

24 ott 2025, 18:00 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By Two to 420 -- Market Talk

DJ

LeggI

24 ott 2025, 16:57 UTC

Utili

Ford Stock Has Quadrupled Tesla's Gains. What's Behind Its Meteoric Rise. -- Barrons.com

DJ

LeggI

24 ott 2025, 16:54 UTC

Discorsi di Mercato

End to Canada-U.S. Trade Talks Not Seen Shifting Nearterm Outlook -- Market Talk

DJ

LeggI

24 ott 2025, 16:44 UTC

Discorsi di Mercato
Utili

Amazon Retail Looks Strong as Consumer Sentiment Improves -- Market Talk

DJ

LeggI

24 ott 2025, 16:39 UTC

Discorsi di Mercato
Utili

Amazon Sentiment Around AWS Seen as Improving in 3Q -- Market Talk

DJ

LeggI

24 ott 2025, 16:33 UTC

Utili

These Stocks Are Moving the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

DJ

LeggI

24 ott 2025, 16:23 UTC

Utili

These Stocks Are Moving the Most Today: Intel, AMD, Ford, Deckers, Newmont, Nextracker, Booz Allen, Coinbase, and More -- Barrons.com

DJ

LeggI

24 ott 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

DJ

LeggI

24 ott 2025, 16:07 UTC

Utili

Ford Stock Has Quadrupled Tesla's Gains. What's Behind Its Meteoric Rise. -- Barrons.com

DJ

LeggI

Confronto tra pari

Modifica del prezzo

Inovio Pharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

209.33% in crescita

Previsioni per 12 mesi

Media 6.96 USD  209.33%

Alto 13 USD

Basso 1.8 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Inovio Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

4

Acquista

1

Mantieni

0

Vendi

Basato sugli analisti di 5 che hanno fornito valutazioni azionarie a Inovio Pharmaceuticals Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

1.76 / 1.94Supporto e resistenza

A breve termine

Bullish Evidence

Recent bullish events outweigh bearish events.

A termine intermedio

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

A lungo termine

No Evidence

There are no events.

Sentiment

By Acuity

145 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

$

Altri titoli del settore

JNJ

Johnson and Johnson

190.6

↓-0.77%

ABT

Abbott Laboratories

126.77

↑ +0.33%

MDT

Medtronic PLC

93.77

↓-0.45%

VEEV

Veeva Systems Inc

293.21

↑ +0.68%

A

Agilent Technologies Inc

148.21

↑ +0.39%
help-icon Live chat